Owlstone Medical Ltd.. (3/7/19). "Press Release: University of Manchester and Owlstone Medical Partner on £250,000 Grant from Asthma UK and Innovate UK for Asthma Diagnostic Development". Manchester & Cambridge. |
2019-03-07 |
Owlstone Medical Ltd.. (3/5/18). "Press Release: Owlstone Medical Raises $15 Million USD (£11 Million GBP) with Horizons Ventures and Aviva". Cambridge. |
2018-03-05 |
Owlstone Medical Ltd.. (3/30/20). "Press Release: Owlstone Medical Appoints Neil Tween as Chief Financial Officer". Cambridge. |
2020-03-30 |
Owlstone Medical Ltd.. (3/15/23). "Press Release: Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection". Cambridge. |
2023-03-15 |
Owlstone Medical Ltd.. (12/10/19). "Press Release: Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure". Cambridge. |
2019-12-10 |
Owlstone Medical Ltd.. (11/7/19). "Press Release: Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-invasive Breath Biopsy". Cambridge. |
2019-11-07 |
Owlstone Medical Ltd.. (11/27/17). "Press Release: Owlstone Medical’s Breath Biopsy Platform Integrated into GSK’s Phase II Respiratory Disease Clinical Trial". Cambridge. |
2017-11-27 |
Owlstone Medical Ltd.. (10/10/18). "Press Release: Owlstone Medical Appoints Dr Richard A Yost to Scientific Advisory Board". Cambridge. |
2018-10-10 |
Owlstone Medical Ltd.. (10/1/18). "Press Release: Owlstone Medical Completes $50 Million USD (c.£38 Million GBP) Financing Round". Cambridge. |
2018-10-01 |
Owlstone Medical Ltd.. (1/6/17). "Press Release: Owlstone Medical Announces $11.55m USD Fundraising". Cambridge. |
2017-01-06 |
Ovizio Imaging Systems NV/SA. (6/25/18). "Press Release: Ovizio Imaging Systems Appoints Dr. Emilie Viey as Chief Executive Officer". Brussels. |
2018-06-25 |
Oviva Ltd.. (9/1/21). "Press Release: Oviva Raises $80m in Series C Funding to Give Millions of People across Europe Access to Personalised, App-based Diet and Lifestyle Coaching". London. |
2021-09-01 |
Osteolabs GmbH. (4/29/21). "Press Release: Osteolabs GmbH Establishes UK Presence". Kiel & Marlow. |
2021-04-29 |
OSE Immunotherapeutics S.A.. (10/7/22). "Press Release: OSE Immunotherapeutics Appoints Nicolas Poirier as Chief Executive Officer". Nantes. |
2022-10-07 |
Osborne Clarke. (3/2/21). "Press Release: Osborne Clarke Advises Oxular on Its £27M Financing". |
2021-03-02 |
Oryzon Genomics S.A.. (5/14/18). "Press Release: Oryzon Announces First Patients In ETHERAL – a Phase IIa Clinical Trial in Alzheimer’s Disease with ORY-2001". Madrid & Cambridge, MA. |
2018-05-14 |
Orna Therapeutics. (2/24/21). "Press Release: Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies". Cambridge, MA. |
2021-02-24 |
Ori Biotech Ltd.. (9/13/22). "Press Release: Ori Biotech and CTMC Partner to Accelerate Novel Cell Therapy Delivery". London & Houston, TX. |
2022-09-13 |
Ori Biotech Ltd.. (8/30/22). "Press Release: Ori Biotech Adds to Senior Team, Scientific Advisory Board and Expands Global Footprint". London. |
2022-08-30 |
Ori Biotech Ltd.. (8/25/21). "Press Release: Ori Biotech Expands Board of Directors and Scientific Advisory Board". London. |
2021-08-25 |
Ori Biotech Ltd.. (7/28/20). "Press Release: Ori Biotech Appoints Thomas Heathman, PhD to Lead Commercial Operations in North America". Philadeliphia, PA & London. |
2020-07-28 |
Ori Biotech Ltd.. (4/14/21). "Press Release: ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform for Cell and Gene Therapy Developers". London & Woodcliff Lake, NJ. |
2021-04-14 |
Ori Biotech Ltd.. (12/15/22). "Press Release: Ori Biotech and Inceptor Bio Partner to Accelerate Solid Tumor Cell Therapy Access". London & Morrisville, NC. |
2022-12-15 |
Ori Biotech Ltd.. (12/15/20). "Press Release: Ori Biotech Adds to Its World-Class Team". London & Woodcliff Lake, NJ. |
2020-12-15 |
Ori Biotech Ltd.. (10/14/20). "Press Release: Ori Biotech Raises $30 Million in Series A Financing to Advance Innovation in Cell and Gene Therapy Manufacturing". London & Woodcliff Lake, NJ. |
2020-10-14 |
Ori Biotech Ltd.. (1/8/20). "Press Release: Ori Biotech Announces a $9.4m Seed Round to Advance Innovation in Cell and Gene Therapy Manufacturing". London & Philadelphia, PA. |
2020-01-08 |
Ori Biotech Ltd.. (1/18/22). "Press Release: Ori Biotech Raises over $100 Million in Series B Funding to Launch Innovative Cell and Gene Therapy Manufacturing Platform". London. |
2022-01-18 |
Orchard Therapeutics Ltd.. (8/29/18). "Press Release: Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources". Boston, MA & London. |
2018-08-29 |
Orchard Therapeutics Ltd.. (8/22/17). "Press Release: Orchard Therapeutics Announces that OTL-101 Has Received a Designation as Promising Innovative Medicine by UK’s Regulatory Agency". London. |
2017-08-22 |
Orchard Therapeutics Ltd.. (8/13/18). "Press Release: Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline". Boston, MA & London. |
2018-08-13 |
Orchard Therapeutics Ltd.. (8/10/17). "Press Release: Orchard Therapeutics Appoints Mark Rothera as CEO". London. |
2017-08-10 |
Orchard Therapeutics Ltd.. (5/3/18). "Press Release: Orchard Therapeutics’ OTL-200 Receives Rare Pediatric Disease Designation from FDA for Treatment of Metachromatic Leukodystrophy". Boston, MA & London. |
2018-05-03 |
Orchard Therapeutics Ltd.. (4/24/18). "Press Release: Orchard Therapeutics Expands US Presence with New Corporate Office in Boston". Boston, MA & London. |
2018-04-24 |
Orchard Therapeutics Ltd.. (3/27/19). "Press Release: Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD". Boston, MA & London. |
2019-03-27 |
Orchard Therapeutics Ltd.. (3/21/19). "Press Release: Orchard Therapeutics Reports 2018 Financial Results and Reviews Recent Business Highlights". Boston, MA & London. |
2019-03-21 |
Orchard Therapeutics Ltd.. (3/21/18). "Press Release: Orchard Therapeutics Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer and General Counsel". London. |
2018-03-21 |
Orchard Therapeutics Ltd.. (3/18/19). "Press Release: Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Officer". Boston, MA & London. |
2019-03-18 |
Orchard Therapeutics Ltd.. (2/5/18). "Press Release: Orchard Therapeutics Appoints Dr. Harry Malech to Scientific Advisory Board". London. |
2018-02-05 |
Orchard Therapeutics Ltd.. (2/25/19). "Press Release: Orchard Therapeutics Presents Clinical Proof-of-Concept Data for OTL-102 for the Treatment of X-CGD". Boston, MA & London. |
2019-02-25 |
Orchard Therapeutics Ltd.. (2/22/19). "Press Release: Orchard Therapeutics Presents Two-year Follow-up Data Versus Historical Control from Registrational Trial of OTL-101 for the Treatment of ADA-SCID". Boston, MA & London. |
2019-02-22 |
Orchard Therapeutics Ltd.. (12/20/17). "Press Release: Orchard Therapeutics Announces $110m Series B Financing to Advance Transformative Gene Therapy Pipeline". London. |
2017-12-20 |
Orchard Therapeutics Ltd.. (12/15/17). "Press Release: Orchard Therapeutics and Généthon Announce Gene Therapy Alliance in X-linked Chronic Granulomatous Disease". London & Évry. |
2017-12-15 |
Orchard Therapeutics Ltd.. (12/14/18). "Press Release: Orchard Therapeutics and Sirion Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency". Boston, London & Martinsried. |
2018-12-14 |
Orchard Therapeutics Ltd.. (12/13/18). "Press Release: Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California". Boston, MA & London. |
2018-12-13 |
Orchard Therapeutics Ltd.. (11/5/18). "Press Release: Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, including the Partial Exercise of Underwriters’ Option". Boston, MA & London. |
2018-11-05 |
Orchard Therapeutics Ltd.. (10/30/18). "Press Release: Orchard Therapeutics Announces Pricing of Initial Public Offering". Boston, MA & London. |
2018-10-30 |
Orchard Therapeutics Ltd.. (1/7/19). "Press Release: Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy". Boston & London. |
2019-01-07 |
Orchard Therapeutics Ltd.. (1/17/18). "Press Release: Orchard Therapeutics Appoints Frank Thomas as Chief Financial Officer and Chief Business Officer". London. |
2018-01-17 |
Orbit Discovery Ltd.. (9/11/23). "Press Release: Orano Med and Orbit Discovery Enter Collaboration to Discover Novel Targeted Radioligand Therapies for Cancer". Texas & Oxford. |
2023-09-11 |
Orbit Discovery Ltd.. (8/30/19). "Press Release: Mario Polywka Joins Orbit Discovery’s Board of Directors". Oxford. |
2019-08-30 |
Orbit Discovery Ltd.. (6/29/21). "Press Release: Orbit Discovery Appoints Dr Neil Butt as Chief Executive Officer". Oxford. |
2021-06-29 |
Orbit Discovery Ltd.. (5/23/18). "Press Release: Peptide Display Company Orbit Discovery Closes £6.9M Series A Financing". Oxford. |
2018-05-23 |
Orbit Discovery Ltd.. (11/23/18). "Press Release: Orbit Discovery Awarded Innovate UK Grant to Find TCR Off-target Effects". |
2018-11-23 |
OrbiMed Advisors LLC. (5/3/23). "Press Release: OrbiMed Expands to Europe, Opens London Office". New York, NY. |
2023-05-03 |
OrbiMed Advisors LLC. (10/24/23). "Press Release: OrbiMed Raises $4.3 Billion Across Private Investment Funds". New York, NY. |
2023-10-24 |
Optimapharm d.d.. (7/21/20). "Press Release: Optimapharm Appoints Dr. Andrew Copestake as Chief Executive Officer". |
2020-07-21 |
Optibrium Ltd.. (9/4/18). "Press Release: Optibrium and Enamine Collaboration Extends Commercial Compound Database Access for StarDrop Users". Cambridge & Kiev. |
2018-09-04 |
Optibrium Ltd.. (9/11/18). "Press Release: Optibrium and Intellegens Collaborate to Apply Novel Deep Learning Methods to Drug Discovery". Cambridge. |
2018-09-11 |
Optibrium Ltd.. (8/31/23). "Press Release: Optibrium Acquires BioPharmics LLC, Expanding Its 3D Drug Design and Visualisation Offering". Cambridge. |
2023-08-31 |
Optibrium Ltd.. (5/12/20). "Press Release: Optibrium Adopts Cheminformatics Toolkits From OpenEye Scientific". Cambridge & Santa Fe, NM. |
2020-05-12 |
Optibrium Ltd.. (4/11/17). "Press Release: Lhasa and Optibrium Enter Research and Product Development Collaboration". Cambridge & Leeds. |
2017-04-11 |
Optibrium Ltd.. (2/17/20). "Press Release: Optibrium Appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development". Cambridge. |
2020-02-17 |
Optibrium Ltd.. (10/10/17). "Press Release: Optibrium Joins EUR 40 Million eTRANSAFE Project". Cambridge. |
2017-10-10 |
Optibrium Ltd.. (1/31/17). "Press Release: Optibrium Signs Agreement with Zastra Innovations for Distribution in India". Cambridge & Bengaluru. |
2017-01-31 |
Optibrium Ltd.. (1/30/18). "Press Release: Optibrium Expands US and UK Operations". Cambridge. |
2018-01-30 |
Optibrium Ltd.. (1/28/19). "Press Release: Optibrium Strengthens Senior Management Team with Financial Director Appointment". Cambridge. |
2019-01-28 |
Optibrium Ltd.. (1/17/23). "Press Release: Optibrium Appoints Steve Yemm as Chief Commercial Officer". Cambridge. |
2023-01-17 |
Optibrium Ltd.. (1/12/17). "Press Release: Optibrium and eMolecules Collaborate on Chemistry Data Integration in StarDrop". Cambridge & La Jolla, CA. |
2017-01-12 |
OptiBiotix Health plc. (3/21/17). "Press Release: Intention to Float SkinBioTherapeutics". |
2017-03-21 |
Open Pharma Research Ltd.. (7/23/19). "Press Release: Lab of the Future Congress, 13-14th November 2019, Cambridge UK". Cambridge. |
2019-07-23 |
Onyx Health. (9/15/20). "Press Release: Onyx Health Launches International PR Partnership with US Agency Jeff Winton Associates". |
2020-09-15 |
Onego Bio Ltd.. (2/22/22). "Press Release: Finnish Startup Onego Bio Ltd Raises EUR 10M in Seed Funding to Commercialize a Breakthrough Technology to Produce Egg White without Chickens". Helsinki. |
2022-02-22 |
One Nucleus. (7/25/17). "Press Release: Instinctif Partners Becomes Latest Partner of One Nucleus". Cambridge. |
2017-07-25 |
One Nucleus. (7/17/17). "Press Release: New Chief Executive for One Nucleus". Cambridge. |
2017-07-17 |
One Nucleus. (6/2/17). "Press Release: New Event to Advance Disruptive Thinking in Healthcare Innovation". London. |
2017-06-02 |
One Nucleus. (2/13/17). "Press Release: One Nucleus Announces New Director". Cambridge. |
2017-02-13 |
Oncodesign S.A.. (2/24/22). "Press Release: Abzena, Alira Health and Oncodesign Launch DRIVE-Biologics to Support Access to Specialist Services from Discovery to Clinical Development for Oncology and Inflammation". Cambridge, Framingham, MA & Dijon. |
2022-02-24 |
Oncimmune Holdings plc. (9/24/18). "Press Release: Adam Hill Appointed as CEO and Geoffrey Hamilton-Fairley Transitions to Vice Chairman". Nottingham. |
2018-09-24 |
Oncimmune Holdings plc. (9/20/19). "Press Release: €8.5m Credit Facility Secured. Funding to Accelerate the Further Commercialisation of Oncimmune’s Lead Products and Services". |
2019-09-20 |
Oncimmune Holdings plc. (6/28/19). "Press Release: Oncimmune Secures Strategic Commercialisation Agreement for EarlyCDT Lung in the US with Biodesix, Inc.". London. |
2019-06-28 |
Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA. |
2019-03-19 |
Omnix Medical Ltd.. (11/20/20). "Press Release: Omnix Medical Announces Successful $8.5 Million Funding Round". |
2020-11-20 |
OMass Therapeutics Ltd.. (5/8/19). "Press Release: OMass Therapeutics Appoints Rosamond Deegan as Chief Executive Officer". Oxford. |
2019-05-08 |
OMass Therapeutics Ltd.. (4/28/22). "Press Release: OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases". Oxford. |
2022-04-28 |
OMass Therapeutics Ltd.. (2/17/20). "Press Release: OMass Therapeutics Announces £27.5 Million Extended Series A Financing". Oxford. |
2020-02-17 |
OMass Therapeutics Ltd.. (11/27/18). "Press Release: OMass Therapeutics Expands Its Senior Leadership Team". |
2018-11-27 |
OMass Therapeutics Ltd.. (11/21/18). "Press Release: OMass Therapeutics Announces £14 Million Series A Financing to Build a Pipeline of Proprietary Medicines". Oxford. |
2018-11-21 |
OMass Technologies Ltd.. (7/11/18). "Press Release: OMass Technologies Announces Publication Demonstrating the Impact of Lipid Interactions on GPCR Signalling in Nature". Oxford. |
2018-07-11 |
OMass Technologies Ltd.. (6/15/17). "Press Release: OMass Technologies Secures Innovate UK Funding in Collaboration with the University of Oxford". Oxford. |
2017-06-15 |
Okyo Pharma Ltd.. (5/19/22). "Press Release: Okyo Pharma Limited Announces Closing of Public Offering and Nasdaq Listing". London. |
2022-05-19 |
Okra Technologies Ltd.. (11/15/19). "Press Release: Okra Becomes a Veeva Technology Partner". Cambridge. |
2019-11-15 |
Ogilvy. (7/8/21). "Press Release: Ogilvy Names Prominent Health Industry Leader Kim Johnson Global CEO of Ogilvy Health". New York, NY. |
2021-07-08 |
Ogilvy. (10/27/20). "Press Release: Ogilvy Appoints Kate Cronin to Global Role as CEO of Ogilvy Health". New York, NY. |
2020-10-27 |
Odyssey Therapeutics, Inc.. (12/7/21). "Press Release: Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines". Boston, MA. |
2021-12-07 |
Odyssey Therapeutics, Inc.. (12/5/23). "Press Release: Odyssey Therapeutics Announces $101 Million Series C Financing". Boston, MA. |
2023-12-05 |
Oculis Holding AG. (3/3/23). "Press Release: Oculis Announces US Public Listing on NASDAQ". Lausanne & Zug. |
2023-03-03 |
Ochre Bio Ltd.. (6/16/21). "Press Release: Ochre Bio Closes $9.6M Seed Financing Led by Khosla Ventures". Oxford. |
2021-06-16 |
OBN (UK) Ltd.. (6/20/17). "Press Release: OBN (UK) and Eurasanté (FR) Announce the Launch of BioSeed. A New European Equity Investment Event to Support Early-Stage Companies in Life Sciences". Oxford. |
2017-06-20 |
OBN (UK) Ltd.. (4/27/18). "Press Release: OBN Concludes Hugely Successful BioTrinity 2018 Conference". Abingdon. |
2018-04-27 |
OBN (UK) Ltd.. (4/20/17). "Press Release: OBN Appoints New Director to Enhance Board Expertise". Abingdon. |
2017-04-20 |